Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GeneGo, a provider of software and databases for systems biology, has announced that Merck & Co has extended its global enterprise agreement.
Subscribe to our email newsletter
This agreement provides Merck with access to GeneGo’s content through MetaBase which includes access to MetaCore and MetaDrug content and GeneGo’s internal database of disease biomarkers.
Julie Bryant, vice president of business development at GeneGo, said: “Effective use of powerful systems biology data mining & analysis solutions have become an essential component of modern day drug discovery and development. Merck is one of our first customers and we are pleased that they have chosen to renew and extend their agreement.”